An open‐label trial of oral CA‐4948 an IRAK4 inhibitor combined with ibrutinib in adult patients with relapsed or refractory hematologic malignancies Meeting Abstract
| Authors: | Joffe, E.; Ramchandren, R.; Nowakowski, G.; Rosenthal, A.; Tun, H. W.; Lunning, M.; Mead, M. D.; Martinez, E.; von Roemeling, R.; Leslie, L. |
| Abstract Title: | An open‐label trial of oral CA‐4948 an IRAK4 inhibitor combined with ibrutinib in adult patients with relapsed or refractory hematologic malignancies |
| Meeting Title: | 16th International Conference on Malignant Lymphoma - Virtual Edition |
| Journal Title: | Hematological Oncology |
| Volume: | 39 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2021 Jun 18-22 |
| Meeting Location: | Virtual |
| ISSN: | 0278-0232 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2021-06-01 |
| Start Page: | 348 |
| Language: | English |
| ACCESSION: | 150945533 |
| DOI: | 10.1002/hon.169_2880 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| PUBMED: | 34105791 |
| DOI/URL: | |
| Notes: | Meeting Abstract 257 -- Accession Number: 150945533 -- Entry Date: In Process -- Revision Date: 20210618 -- Publication Type: Article -- Supplement Title: Jun2021 Supplement S2 -- Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 8307268. -- Source: Cinahl |
